Possibilities of clinical repercussions resulting from the occurrence of covid-19 during pregnancy: integrative review
DOI:
https://doi.org/10.47456/rbps.v25i1.39626Keywords:
Covid-19, Infectious Complications in Pregnancy, Mortality, Vertical Transmission of Infectious DiseasesAbstract
Introduction: Considering the panorama of the pandemic and the experience in the management of complicated pregnancies resulting from infections with other coronaviruses, the vulnerability of pregnant women to SARS-CoV-2 was considered. Objectives: Analyze the scientific evidence and describe the main maternal and fetal complications associated with covid-19 during pregnancy. Methods: This is an integrative literature review, adapted following the Prisma method. Data collection took place through the following databases: National Library of Medicine National Institutes of Health (PubMed) and Science Direct. The descriptors and keywords were: “COVID-19”; “Pregnancy Complications Infectious”; “Mortality”; “Infectious Disease Transmission Vertical”. Results: Fifteen studies were included in this review, showing that pregnant women with covid-19 in a serious condition may have complications such as the need for Intensive Care Unit (ICU) (40%), pneumonia (33.4%), maternal death (33.4%) and preeclampsia. (20%). Among the fetal and neonatal complications, 60% corresponded to premature birth. In addition, the possibility of vertical transmission was reported. Conclusion: It is known that there are correlations of viral infections with repercussions and damage to maternal and fetal health. However, the specific complications of covid-19 and its severity in pregnant women, vertical transmission, perinatal and neonatal complications, are not completely understood. However, it a possible explanation for the difficulty in establishing a causal relationship is the symptoms of pregnancy.
Downloads
References
Organização Pan-Americana da Saúde, Organização Mundial da Saúde [Internet]. Alerta Epidemiológico Complicações e sequelas da COVID-19. Washington, D.C.: PAHO/WHO; 2020 [acesso em 18 mar. 2022]. Disponível em: 20Complicacoes%20 e%20sequelas%20da%20COVID-19.pdf
Griffin DO, Brennan-Rieder D, Ngo B, Kory P, Confalonieri M, Shapiro L, et al. The importance of understanding the stages of COVID-19 in treatment and trials. AIDS Rev. 2021;23:40-47.
World Health Organization (WHO) [Internet]. Coronavirus (COVID-19). Genebra: WHO; 2020 [acesso em 5 abr. 2022]. Dis¬ponível em: https://covid19.who.int/table
Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: ret¬rospective case series. BMJ, 2020;368:m606.
Hernández Rodríguez J. Aspectos clínicos relacionados con el Síndrome Respiratorio Agudo Severo (SARS-CoV-2). Rev haba¬nera cienc méd. 2020;19(0):e3279.
Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogene¬sis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiol. 2020;15(13):1287- 1305.
Souza WM, Buss LF, Candido DS, Carrera J-P, Li S, Zarebski AE, et al. Epidemiological and clinical characteristics of the COVID- 19 epidemic in Brazil. Nat Hum Behav. 2020;4(8):856-865.
Schwartz DA, Dhaliwal A. Coronavirus diseases in pregnant women, the placenta, fetus, and neonate. Adv Exp Med Biol. 2021;1318:223-241.
Wastnedge EA, Reynolds RM, van Boeckel SR, Stock SJ, Deni¬son FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Ver. 2021; 101(1):303-318.
Fracarolli IF, Oliveira SA, Marziale MH. Colonização bacteriana e resistência antimicrobiana em trabalhadores de saúde: revisão integrativa. Acta Paul Enferm. 2017;30(6):651-657.
Stillwell SB, Fineout-Overholt E, Melnyk BM, Williamson KM. Evidence-based practice, step by step: asking the clinical ques¬tion: a key step in evidence-based practice: A key step in evi¬dence-based practice. Am J Nurs. 2010;110(3):58-61.
Melnyk BM. Making the case for evidence-based practice. In: editor. Evidence-based practice in nursing & healthcare: a guide to best practice. Philadelphia: Lippincott Williams & Wilkins; 2005.
Abedzadeh-Kalahroudi M, Sehat M, Vahedpour Z, Talebian P, Haghighi A. Clinical and obstetric characteristics of pregnant women with Covid-19: A case series study on 26 patients. Tai¬wan J Obstet Gynecol. 2021; 60(3):458-462.
Pierce-Williams RA, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM. 2020;2(3):100134.
Dhir SK, Kumar J, Meena J, Kumar P. Clinical features and out¬come of SARS-CoV-2 infection in neonates: A systematic review. J Trop Pediatr. 2021;67(3):fmaa059
Yan J, Guo J, Fan C, Juan J, Yu X, Li J, Feng L, et al. Corona¬virus disease 2019 in pregnant women: a report based on 116 cases. American Journal of Obstetrics and Gynecology. 2020;223(1):111.e1-111.e14.
Capobianco G, Saderi L, Aliberti S, Mondoni M, Piana A, Des¬sole F, Dessole M, Cherchi PL, Dessole S, Sotgiu G. COVID-19 in pregnant women: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2020;252:543-558.
Karimi L, Makvandi S, Vahedian-Azimi A, Sathyapalan T, Sahebkar A. Effect of COVID-19 on mortality of pregnant and postpartum women: A systematic review and meta-analysis. J Pregnancy. 2021; 2021:8870129.
Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meu¬len J, Gurol-Urganci I, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. The Lancet. Global Health. 2021;9(6):e759-e772.
Richtmann R, Torloni MR, Oyamada Otani AR, Levi JE, Crema Tobara M, de Almeida Silva C, et al. Fetal deaths in pregnancies with SARS-CoV-2 infection in Brazil: A case series. Case Rep Womens Health. 2020;27:e00243.
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstetricia et Gynecologica Scandinavica. 2020;99(7):823-829.
Novoa RH, Quintana W, Llancarí P, Urbina-Quispe K, Gue¬vara-Ríos E, Ventura W. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review. Travel Medicine and Infec¬tious Disease. 2021;39(101919):101919.
Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Maternal death due to COVID-19. Am J Obstet Gynecol. 2020;223(1):109.e1-109.e16.
Aghaamoo S, Ghods K, Rahmanian M. Pregnant women with COVID-19: the placental involvement and consequences. J Mol Histol. 2021;52(3):427-435.
Czeresnia RM, Trad AT, Britto IS, Negrini R, Nomura ML, Pires P, et al. SARS-CoV-2 and pregnancy: A review of the facts. Rev Bras Ginecol Obstet. 2020;42(9):562-568.
Khalil A, Kalafat E, Benlioglu C, O’Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Heath P, Ladhani S, von Dadelszen P, Magee LA. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy out¬comes. EClinicalMedicine. 2020;25(100446):100446.
Foo S-S, Cambou MC, Mok T, Fajardo VM, Jung KL, Fuller T, et al. The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of moth¬er-infant dyads with in utero SARS-CoV-2. Cell Rep Med. 2021;2(11):100453.
Barbosa ML da S, Silva ME de B, Silva JE da, Silva D de L, Lima Filho CA de, Rafael KJ, et al. Complicações obstétricas e perinatais durante a pandemia do COVID-19. Res Soc Dev. 2021;10(14):e32101421661.
Souza AS, Amorim MM. Maternal mortality by COVID-19 in Brazil. Rev Bras Saúde Materno Infant. 2021;21(suppl 1):253-256.
Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, et al. Birth and infant outcomes following labora¬tory-confirmed SARS-CoV-2 infection in pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1635-1640.
Vega Rojas D, Carreño Manríquez L, Díaz Echeverría C. Pronóstico Perinatal en embarazadas de tercer trimestre recu¬peradas de infección por COVID-19. Rev Chil Obstet Ginecol. 2020;85:S23-27.
Costa K, Ribeiro L, De Jesus J, Costa Karina, Fernandes G, Spilski J, et al. Olfactory sensory evaluation in newborn children of women infected with COVID-19 during pregnancy. J Hum Growth Dev. 2021;31(2):192-198.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. A declaração PRISMA 2020: uma diretriz atualizada para relatar revisões sistemáticas. BMJ. 2021;372:n71.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
